'Anti tnf' diaporamas de présentation

Dr. X. Baraliakos Rheumazentrum Ruhrgebiet, Herne Ruhr-University Bochum Germany

Anti-TNF therapy in ankylosing spondylitis - Clinical and structural outcomes -. Dr. X. Baraliakos Rheumazentrum Ruhrgebiet, Herne Ruhr-University Bochum Germany. Ankylosing spondylitis: a chronic inflammatory rheumatic disease leading to high clinical impairment. 24 years.

957 views • 74 slides

Internal and Perianal Fistulas: Current Treatment Approach

Internal and Perianal Fistulas: Current Treatment Approach. David A. Schwartz, MD Director, Inflammatory Bowel Disease Center Associate Professor of Medicine Vanderbilt University Medical Center. Internal Fistula Patient.

964 views • 56 slides

993 views • 49 slides

602 views • 49 slides

GENOVA 26 NOVEMBRE 2011

MALATTIE INFIAMMATORIE CRONICHE INTESTINALI : I LIMITI DELLA TERAPIA TRADIZIONALE. QUANDO INIZIARE I FARMACI BIOLOGICI?. GENOVA 26 NOVEMBRE 2011 XI CONGRESSO TRISOCIETARIO

638 views • 49 slides

Overview

Safety & Tolerability of Biologics Dubai, United Arab Emirates January 19th, 2009 Prof. Joachim R. Kalden Director emeritus Department of Internal Medicine III Div. of Molecular Immunology Niklolaus-Fiebiger-Center University of Erlangen-Nuremberg. Overview. Monitoring of safety: registries

544 views • 39 slides

Unconventiional Therapies: What to do when all else fails?

479 views • 38 slides

487 views • 35 slides

IBD: What drugs in what patients?

IBD: What drugs in what patients?. Stephen B. Hanauer, MD Professor of Medicine Feinberg School of Medicine Medical Director, Digestive Health Center Northwestern Medicine. Conflicts AbbVie , Actavis , Janssen, Pfizer, Prometheus, Salix, Shire, Takeda, UCB. IBD in 2014: Therapeutic Goals.

750 views • 34 slides

Rituximab is Approved After Failure with 1 anti-TNF a Inhibitor

Rheumatoid Arthritis: Expanding Treatment Options HIGHLIGHTS FROM EULAR 2008 PRESENTATIONS June 11-14, 2008 Paris, France. Is there a benefit to using Rituximab, instead of another TNF a -inhibitor, when a patient has already failed a TNF a -inhibitor?

510 views • 32 slides

IBD Cases

IBD Cases. Stephen B. Hanauer, MD Professor of Medicine Feinberg School of Medicine Medical Director, Digestive Health Center. What options are available for treatment of this patient ?. Management Algorithm. Ulcerative Colitis. MODERATE. MILD. SEVERE. 5ASA +/- prednisone.

628 views • 32 slides

Disease causation- the big picture

Advances in the pathogenesis and management of SLE Anne Davidson MBBS Feinstein Institute for Medical Research, Manhasset NY. Chance/Fate. Environment. Genetic risk. Innate and adaptive immune responses. Disease phenotype. Amplification. Target organ damage.

433 views • 31 slides

Robert N. Baldassano, MD Colman Professor of Pediatrics

What do we do when the patient loses their response to an anti-TNF: Minor tweaks or major treatment changes?. Robert N. Baldassano, MD Colman Professor of Pediatrics University of Pennsylvania, Perelman School of Medicine Director, Center for Pediatric IBD

409 views • 29 slides

1.24k views • 22 slides

Jacques-Eric Gottenberg Universitary Hospital of Strasbourg, France

How real life rituximab data supports the use of rituximab following an inadequate response to one TNF inhibitor. Jacques-Eric Gottenberg Universitary Hospital of Strasbourg, France National center for systemic autoimmune diseases. Main objections to rituximab.

460 views • 20 slides

Con arguments: Maxime DOUGADOS

401 views • 20 slides

Therapy of Inflammatory Bowel Diseases 2013

Gastroenterology Department Division of Medicine. Therapy of Inflammatory Bowel Diseases 2013. Eran Israeli MD. 100. 80. Penetrating. 60. % Cumulative Probability. 40. Inflammatory. Stricturing. 20. 0. 0. 12. 24. 36. 48. 60. 72. 84. 96. 108. 120. 132. 144. 156. 168. 180.

270 views • 19 slides

277 views • 17 slides

MabThera in daily clinical practice European Patient Cohorts and Registries MIRA Update

279 views • 15 slides

Predicting Serious Drug Side Effects in Gastroenterology - PRED4

Predicting Serious Drug Side Effects in Gastroenterology - PRED4 International IBD Genetics Consortium Projects www.ibdresearch.co.uk/pred4. Welcome to the OCTOBER 2013 edition of the PRED4 newsletter.

188 views • 2 slides